Randomized Placebo-Controlled Study of Sildenafil For The Treatment of Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis: A Pilot Study

Trial Profile

Randomized Placebo-Controlled Study of Sildenafil For The Treatment of Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis: A Pilot Study

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 08 Mar 2018

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Pulmonary fibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Mar 2018 Status changed from recruiting to withdrawn prior to enrolment as inclusion/exclusion criteria limited enrollment
    • 27 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top